A detailed history of Sky Investment Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sky Investment Group LLC holds 18,458 shares of BMY stock, worth $1.07 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,458
Previous 21,417 13.82%
Holding current value
$1.07 Million
Previous $889,000 7.42%
% of portfolio
0.18%
Previous 0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$39.66 - $51.75 $117,353 - $153,128
-2,959 Reduced 13.82%
18,458 $955,000
Q2 2024

Jul 16, 2024

SELL
$40.25 - $52.99 $14,932 - $19,659
-371 Reduced 1.7%
21,417 $889,000
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $160,924 - $182,457
-3,354 Reduced 13.34%
21,788 $1.18 Million
Q4 2023

Jan 24, 2024

BUY
$48.48 - $57.85 $28,118 - $33,553
580 Added 2.36%
25,142 $1.29 Million
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $5,789 - $6,473
-100 Reduced 0.41%
24,562 $1.43 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $15,927 - $17,685
-250 Reduced 1.0%
24,662 $1.58 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $6,570 - $7,453
100 Added 0.4%
24,912 $1.73 Million
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $14 - $8,375
-109 Reduced 0.44%
24,812 $1.76 Million
Q2 2022

Jul 12, 2022

BUY
$72.62 - $79.98 $72,620 - $79,980
1,000 Added 4.18%
24,921 $1.92 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $2,189 - $2,564
-37 Reduced 0.15%
23,921 $1.42 Million
Q2 2021

Jul 21, 2021

BUY
$61.91 - $67.42 $26,002 - $28,316
420 Added 1.78%
23,958 $1.6 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $11,868 - $13,347
200 Added 0.86%
23,538 $1.49 Million
Q4 2020

Jan 25, 2021

BUY
$57.74 - $65.43 $13,568 - $15,376
235 Added 1.02%
23,338 $1.45 Million
Q3 2020

Oct 08, 2020

BUY
$57.43 - $63.64 $1.33 Million - $1.47 Million
23,103 New
23,103 $1.39 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sky Investment Group LLC Portfolio

Follow Sky Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Investment Group LLC with notifications on news.